A/S Novo Nordisk (Responsible for batch release of finished product; manufacturing unit conducting control/testing of finished product batch; manufacturing unit conducting secondary packaging of finished product; manufacturing unit conducting production of unpackaged product, filtration, filling, and lyophilization of powder)

The drug is used for the treatment and prevention of bleeding during surgical interventions or other invasive procedures in patients with congenital hemophilia (with or without inhibitors), acquired hemophilia, congenital factor VII deficiency, and Glanzmann's thrombasthenia. It is also indicated for the treatment of severe postpartum hemorrhage if standard therapy is ineffective.

Dosage form: powder, lyophilized for injection solution

ATC: B02BD08